United States · Who invested in SmithRx?
SmithRx's investors include BoxGroup, Founders Fund, Citibank, Venrock and Precursor Ventures, and 3 more on record.
2018201920202021202220232024
$9.0MSeries A$60MSeries C
United States · Series C startup
Who invested in SmithRx
Funding summaryUpdated 26 Oct 2026
$69Mraised across 2 rounds since 2018, from 2 sources
$9.0MSeries A$60MSeries C
- Latest round
- Series C, $60MJan 2024
- Step-upi
- 6.7×
- Investors
- 8
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $9.0M Jan 2018
- Biggest round
- $60M Series C · Jan 2024
- Between rounds
- 6 years from the last two
The rounds
- Jan 2024Series C$60M5 new1 returning
Source recorded
- Jan 2018
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Series A2018Series C2024
BoxGroup
Founders Fund
Citibank
Venrock
Precursor Ventures
Four Cities Capital
Future100Founders Fund/ Blumberg
BoxGroupFounders FundCitibankVenrockPrecursor VenturesFour Cities CapitalFuture100Founders Fund/ BlumbergEveryone who backed them
Founders Fund/ Blumbergno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about SmithRx
How much has SmithRx raised?
SmithRx has raised $69M across 2 rounds since 2018.
When did SmithRx last raise?
SmithRx's most recent round was a Series C of $60M in Jan 2024.
What was SmithRx's biggest round?
Its most recent round, $60M in Jan 2024, is also its largest on record.
Who backed SmithRx first?
SmithRx's first round on record, in Jan 2018, was backed by BoxGroup, Future100 and Founders Fund/ Blumberg.
What stage is SmithRx at?
SmithRx's latest named round is a Series C, in Jan 2024.
Where is SmithRx based?
SmithRx is based in the United States.
Companies like SmithRx
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.